TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
Apr 29, 2026
2 min read
14

OPEC+ is expected to approve a modest increase in oil output targets of approximately 188,000 barrels per day (bpd) at its upcoming Sunday meeting. This decision follows a similar hike of 206,000 bpd last month, signaling a consistent policy approach.
The move comes amid significant supply disruptions. A conflict that began on February 28 has led to the closure of the Strait of Hormuz, severely limiting exports from key OPEC+ members such as Saudi Arabia, Iraq, Kuwait, and the UAE. These nations were previously the primary countries within the group with the capacity to increase production.
By proceeding with a planned output increase, OPEC+ appears to be adopting a 'business-as-usual' stance. This strategy aims to project stability in the global oil market despite the regional conflict and the departure of the United Arab Emirates from the group on May 1. The decision suggests an effort to manage supply without overreacting to short-term disruptions.
The oil producer group is maintaining its strategy of incremental output increases. The market will closely watch the final outcome of Sunday's meeting and monitor any further developments in the Middle East that could impact global oil supply chains and energy prices.
Q: How much will OPEC+ increase oil output?
A: The group is expected to raise output targets by approximately 188,000 barrels per day.
Q: Why is this decision significant?
A: It demonstrates a commitment to a stable production policy despite severe export disruptions caused by regional conflict and the closure of the Strait of Hormuz.
Source: Reuters via Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles

01 May 2026
Canada Approves Apotex Generic Ozempic Drug

01 May 2026
RRE Ventures SPAC Raises $250M in Nasdaq IPO